Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?

Henning Wackerhage*, Ivan J. Vechetti, Philipp Baumert, Sebastian Gehlert, Lore Becker, Richard T. Jaspers, Martin Hrabě de Angelis

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

In 1924, Otto Warburg asked “How does the metabolism of a growing tissue differ from that of a non-growing tissue?” Currently, we know that proliferating healthy and cancer cells reprogramme their metabolism. This typically includes increased glucose uptake, glycolytic flux and lactate synthesis. A key function of this reprogramming is to channel glycolytic intermediates and other metabolites into anabolic reactions such as nucleotide-RNA/DNA synthesis, amino acid-protein synthesis and the synthesis of, for example, acetyl and methyl groups for epigenetic modification. In this review, we discuss evidence that a hypertrophying muscle similarly takes up more glucose and reprogrammes its metabolism to channel energy metabolites into anabolic pathways. We specifically discuss the functions of the cancer-associated enzymes phosphoglycerate dehydrogenase and pyruvate kinase muscle 2 in skeletal muscle. In addition, we ask whether increased glucose uptake by a hypertrophying muscle explains why muscularity is often negatively associated with type 2 diabetes mellitus and obesity.

Original languageEnglish
Pages (from-to)2569-2578
Number of pages10
JournalSports Medicine
Volume52
Issue number11
Early online date23 Apr 2022
DOIs
Publication statusPublished - Nov 2022

Bibliographical note

Funding Information:
Open Access funding enabled and organized by Projekt DEAL. PB is supported by the EuroTech Postdoc Programme (Grant Agreement Number 754462), co-funded by the European Commission under its framework programme Horizon 2020. Work on this research (HW, PB) is additionally supported by a grant to the Deutsche Diabetes Stiftung.

Publisher Copyright:
© 2022, The Author(s).

Funding

Open Access funding enabled and organized by Projekt DEAL. PB is supported by the EuroTech Postdoc Programme (Grant Agreement Number 754462), co-funded by the European Commission under its framework programme Horizon 2020. Work on this research (HW, PB) is additionally supported by a grant to the Deutsche Diabetes Stiftung.

FundersFunder number
Deutsche Diabetes Stiftung
EuroTech Postdoc Programme
Horizon 2020 Framework Programme754462
European Commission

    Fingerprint

    Dive into the research topics of 'Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?'. Together they form a unique fingerprint.

    Cite this